In reply to: Enalapril and the VEGFA gene: personalized medicine in hypertension therapy
详细信息 查看全文
- 作者：G. H. Oliveira-Paula ; R. Lacchini…
- 刊名：European Journal of Clinical Pharmacology
- 出版年：2016
- 出版时间：January 2016
- 年：2016
- 卷：72
- 期：1
- 页码：127-128
- 全文大小：193 KB
- 参考文献：1.Oliveira-Paula GH, Lacchini R, Fontana V, Silva PS, Biagi C, Tanus-Santos JE (2015) Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril. Eur J Clin Pharmacol 71(8):949–957PubMed CrossRef
2.Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER (2003) The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107(10):1359–1365PubMed CrossRef
3.Facemire CS, Nixon AB, Griffiths R, Hurwitz H, Coffman TM (2009) Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 54(3):652–658PubMed PubMedCentral CrossRef
4.Sandrim VC, Luizon MR, Izidoro-Toledo TC, Coelho EB, Moreno Jr H, Tanus-Santos JE (2013) Functional VEGF haplotypes affect the susceptibility to hypertension. J Hum Hypertens 27(1):31–37PubMed CrossRef
5.Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2009) Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 15(2):115–120PubMed CrossRef
6.Lacchini R, Luizon MR, Gasparini S, Ferreira-Sae MC, Schreiber R, Nadruz Jr W, Tanus-Santos JE (2014) Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 113(3):491–496PubMed CrossRef
7.Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, Okumura K, Murohara T (2008) Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis. Hypertension 51(2):252–258PubMed CrossRef
8.Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P (2004) Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens 17(2):172–180PubMed CrossRef
9.Yazawa H, Miyachi M, Furukawa M, Takahashi K, Takatsu M, Tsuboi K, Ohtake M, Murase T, Hattori T, Kato Y, Murohara T, Nagata K (2011) Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats. J Card Fail 17(12):1041–1050PubMed CrossRef
10.Silva PS, Fontana V, Palei AC, Sertorio JT, Biagi C, Tanus-Santos JE (2011) Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. Eur J Clin Pharmacol 67(4):365–370PubMed CrossRef
11.Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41(4):1149–1160PubMed CrossRef
12.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama 289(19):2560–2572PubMed CrossRef - 作者单位：G. H. Oliveira-Paula (1)
R. Lacchini (2)
J. E. Tanus-Santos (1)
1. Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049-900, Brazil
2. Department of Psychiatric Nursing and Human Sciences, Ribeirao Preto College of Nursing, University of Sao Paulo, Ribeirao Preto, SP, Brazil - 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biomedicine
Pharmacology and Toxicology - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-1041
文摘